{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:13:49Z","timestamp":1778253229452,"version":"3.51.4"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Rett syndrome (RTT) is a rare X-linked progressive neurodevelopmental disorder affecting predominantly females with no cure and a prevalence of ~1 in 10,000 female birth worldwide. Before mutations in the methyl-CpG binding protein 2 (\n                    <jats:italic>MECP2<\/jats:italic>\n                    ) gene were identified to cause classic RTT, there were suggestions that RTT is a mitochondrial disease. Being an essential organelle for all eukaryotic cells, the mitochondria produce energy, buffer calcium, and regulate the generation of reactive oxygen species. Indeed, accumulated reports documented mitochondrial abnormalities in RTT patient biopsies, and animal models and human stem cell models of RTT, including reduced ATP production, altered mitochondrial structure, increased systemic oxidative stress, abnormal calcium activity, mtDNA copy number, and deficiencies in mitochondrial enzyme activity. While it remains unclear how loss of MECP2 function leads to wide-ranging mitochondrial deficits, improving mitochondrial function could still bring benefits to RTT patients. After defining the mitochondrial membrane potential deficit in astrocytes differentiated from RTT patient-specific induced pluripotent stem cells (iPSC), we established a novel high-throughput screening (HTS) platform based on the JC-10 mitochondrial membrane potential (MMP) assay, which served as a rapid primary readout. All primary hits were subsequently validated by independent functional assays to confirm their effects on mitochondrial health. Using this system, we performed a small-molecule screening of 1,134 selected US Food and Drug Administration (FDA)-approved drugs and a small interfering RNA (siRNA) screening of 336 genes upregulated in RTT astrocytes and identified candidate drugs and candidate genes that reversed the MMP deficits in RTT astrocytes. Among the candidate drug hits, isradipine, a dihydropyridine calcium-channel blocker, provided preliminary evidence of neuroprotective effects both\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Among the candidate gene hits,\n                    <jats:italic>LRRC17<\/jats:italic>\n                    , a gene encoding a secreted protein, emerged as a strong candidate mediator whose elevated levels are strongly associated with and likely contribute to various observed cellular deficits. siRNA knockdown of\n                    <jats:italic>LRRC17<\/jats:italic>\n                    not only rescued mitochondrial dysfunction in RTT astrocytes but also reversed deficits in neurons cultured in astrocyte-conditioned media. Our study provides new insights into mitochondrial dysfunction in RTT and establishes an HTS platform for the initial identification of novel therapeutic targets for follow-up studies.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2026.1759410","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:46:21Z","timestamp":1778251581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A high-throughput screening platform to facilitate treatment development in Rett syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanhong","family":"Yin","sequence":"first","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiping","family":"Dong","sequence":"additional","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Bu","sequence":"additional","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Chang","sequence":"additional","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein-2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/088307389000500311","article-title":"Rett syndrome: a mitochondrial disease?","volume":"5","author":"Eeg-Olofsson","year":"1990","journal-title":"J Child Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.euroneuro.2015.03.012","article-title":"Modulation of rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome","volume":"25","author":"De Filippis","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.freeradbiomed.2009.05.016","article-title":"Systemic oxidative stress in classic Rett syndrome","volume":"47","author":"De Felice","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3064016","DOI":"10.1155\/2017\/3064016","article-title":"Increased mitochondrial mass and cytosolic redox imbalance in hippocampal astrocytes of a mouse model of Rett syndrome: subcellular changes revealed by ratiometric imaging of JC-1 and roGFP1 fluorescence","volume":"2017","author":"Bebensee","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e23002","DOI":"10.1002\/jbt.23002","article-title":"Docosahexaenoic acid increased MeCP2 mediated mitochondrial respiratory complexes II and III enzyme activities in cortical astrocytes","volume":"36","author":"Dave","year":"2022","journal-title":"J Biochem Mol Toxicol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2017.00058","article-title":"Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies","volume":"11","author":"Shulyakova","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1093\/hmg\/ddz208","article-title":"Aberrant mitochondrial function in patient-derived neural cells from CDKL5 deficiency disorder and Rett syndrome","volume":"28","author":"Jagtap","year":"2019","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/088307389400900419","article-title":"Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain","volume":"9","author":"Cornford","year":"1994","journal-title":"J Child Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jpeds.2021.09.052","article-title":"Mitochondrial DNA copy number in Rett syndrome caused by methyl-CpG-binding protein-2 variants","volume":"241","author":"Liu","year":"2022","journal-title":"J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1128\/MCB.01665-05","article-title":"Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome","volume":"26","author":"Kriaucionis","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40246-023-00532-1","article-title":"Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach","volume":"17","author":"Pascual-Alonso","year":"2023","journal-title":"Hum Genomics"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.bbadis.2015.07.014","article-title":"Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage","volume":"1852","author":"Cervellati","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/jcm9061669","article-title":"The anti-diabetic drug metformin rescues aberrant mitochondrial activity and restrains oxidative stress in a female mouse model of Rett syndrome","volume":"9","author":"Zuliani","year":"2020","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.1038\/s41598-017-12069-0","article-title":"Retention of mitochondria in mature human red blood cells as the result of autophagy impairment in Rett syndrome","volume":"7","author":"Sbardella","year":"2017","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1016\/j.bbamcr.2014.12.041","article-title":"Mitochondrial quality control: easy come, easy go","volume":"1853","author":"Stotland","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.stem.2013.09.001","article-title":"Global transcriptional and translational repression in human embryonic stem cell-derived Rett syndrome neurons","volume":"13","author":"Li","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"105235","DOI":"10.1016\/j.nbd.2020.105235","article-title":"Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome","volume":"149","author":"Matagne","year":"2021","journal-title":"Neurobiol Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/hmg\/ddq563","article-title":"Reduced AKT\/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model","volume":"20","author":"Ricciardi","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12967-023-04622-5","article-title":"Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome","volume":"21","author":"Musokhranova","year":"2023","journal-title":"J Transl Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s43588-024-00679-4","article-title":"Deep learning large-scale drug discovery and repurposing","volume":"4","author":"Yu","year":"2024","journal-title":"Nat Comput Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cne.22009","article-title":"Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks","volume":"514","author":"Belichenko","year":"2009","journal-title":"J Comp Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mcn.2004.07.006","article-title":"MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions","volume":"27","author":"Kishi","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1523\/JNEUROSCI.3735-16.2017","article-title":"CREB signaling is involved in Rett syndrome pathogenesis","volume":"37","author":"Bu","year":"2017","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"104966","DOI":"10.1016\/j.isci.2022.104966","article-title":"Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome","volume":"25","author":"Zlatic","year":"2022","journal-title":"iScience"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"137629","DOI":"10.1155\/2013\/137629","article-title":"Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients","volume":"2013","author":"Pecorelli","year":"2013","journal-title":"Mediat Inflamm"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"C635","DOI":"10.1152\/ajpcell.00442.2009","article-title":"Intrinsic membrane properties of locus coeruleus neurons in Mecp2-null mice","volume":"298","author":"Zhang","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e19374","DOI":"10.7554\/eLife.19374","article-title":"Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons","volume":"5","author":"Sampathkumar","year":"2016","journal-title":"eLife"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/cr.2016.48","article-title":"Loss of MeCP2 in cholinergic neurons causes part of RTT-like phenotypes via \u03b17 receptor in hippocampus","volume":"26","author":"Zhang","year":"2016","journal-title":"Cell Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nn.2275","article-title":"Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology","volume":"12","author":"Ballas","year":"2009","journal-title":"Nat Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1093\/hmg\/ddu008","article-title":"Mutant astrocytes differentiated from Rett syndrome patient-specific iPSCs have adverse effects on wild-type neurons","volume":"23","author":"Williams","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.3390\/ijms20153813","article-title":"Glial dysfunction in MeCP2 deficiency models: implications for Rett syndrome","volume":"20","author":"Kahanovitch","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0324-09.2009","article-title":"Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions","volume":"29","author":"Maezawa","year":"2009","journal-title":"J Neurosci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"111942","DOI":"10.1016\/j.celrep.2022.111942","article-title":"Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation","volume":"42","author":"Sun","year":"2023","journal-title":"Cell Rep"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"20565","DOI":"10.1038\/s41598-024-71040-y","article-title":"Mitochondrial dysfunction and increased reactive oxygen species production in MECP2 mutant astrocytes and their impact on neurons","volume":"14","author":"Tomasello","year":"2024","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"109296","DOI":"10.1016\/j.isci.2024.109296","article-title":"Mecp2 knock-out astrocytes affect synaptogenesis by interleukin 6 dependent mechanisms","volume":"27","author":"Albizzati","year":"2024","journal-title":"iScience"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1523\/JNEUROSCI.2778-14.2015","article-title":"Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity","volume":"35","author":"Jin","year":"2015","journal-title":"J Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat Genet"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat Biotechnol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e33417","DOI":"10.7554\/eLife.33417","article-title":"Mechanism and consequence of abnormal calcium homeostasis in Rett syndrome astrocytes","volume":"7","author":"Dong","year":"2018","journal-title":"eLife"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/nprot.2006.171","article-title":"Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human cells","volume":"1","author":"Koopman","year":"2006","journal-title":"Nat Pro"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1242\/dmm.006841","article-title":"A translational continuum of model systems for evaluating treatment strategies in Alzheimer\u2019s disease: isradipine as a candidate drug","volume":"4","author":"Copenhaver","year":"2011","journal-title":"Dis Model Mech"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat Genet"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e25255","DOI":"10.1371\/journal.pone.0025255","article-title":"Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model","volume":"6","author":"Ananiev","year":"2011","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/hmg\/ddr093","article-title":"Isolation of MECP2-null Rett syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation","volume":"20","author":"Cheung","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"R10","DOI":"10.1093\/hmg\/ddv217","article-title":"Rett syndrome: disruption of epigenetic control of postnatal neurological functions","volume":"24","author":"Pohodich","year":"2015","journal-title":"Hum Mol Genet"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"10490","DOI":"10.3390\/ijms262110490","article-title":"The Ca2\u207a bridge: from neurons to circuits in Rett syndrome","volume":"26","author":"Calistro","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"110636","DOI":"10.1016\/j.abb.2025.110636","article-title":"Mitochondrial redox imbalance and CoQ10 deficiency in Rett syndrome: insights from patient-derived fibroblasts","volume":"774","author":"Mengarelli","year":"2025","journal-title":"Arch Biochem Biophys"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"15308","DOI":"10.1074\/jbc.M807722200","article-title":"Identification of LRRc17 as a negative regulator of receptor activator of NF-kB ligand (RANKL)-induced osteoclast differentiation","volume":"284","author":"Kim","year":"2009","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1759410\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:46:23Z","timestamp":1778251583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1759410\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":52,"alternative-id":["10.3389\/fneur.2026.1759410"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1759410","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1759410"}}